Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02736448
Brief Title: 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors (Lu-Ca-S)

First Submitted : April 7, 2016
First Submitted that Met QC Criteria : April 12, 2016
First Posted : April 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 26, 2019
Last Update Posted : February 27, 2019